Clinical Trial Update: Somatostatin Receptor Imaging in NPC, EBV Related Cancers [NA]

View source ↗

Summary

This clinical trial update reports completion of a study on somatostatin receptor imaging in nasopharyngeal cancer and Epstein-Barr virus-related carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus-related Carcinoma
• Nasopharyngeal Cancer

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma | NA | Status: COMPLETED